Search results for "embolism"

showing 10 items of 457 documents

The optimal imaging test for diagnosis of acute pulmonary embolism: a second chance for lung scintigraphy?

2020

Ventilation–perfusion scintigraphy may continue to be the first-line diagnostic method for pulmonary embolism in institutions that can ensure its uninterrupted availability and the expertise in its interpretationhttps://bit.ly/2y3Dlhx

Pulmonary and Respiratory Medicinemedicine.medical_specialtyDiagnostic methodsCardiologyScintigraphyVentilation/perfusion ratio03 medical and health sciences0302 clinical medicineVentilation-Perfusion RatiomedicineHumansRadionuclide imaging030212 general & internal medicineRadionuclide ImagingProbabilityLungmedicine.diagnostic_testbusiness.industryfood and beveragesmedicine.diseasePulmonary embolismmedicine.anatomical_structure030228 respiratory systemRadiologyPulmonary EmbolismbusinessEuropean Respiratory Journal
researchProduct

An Original Risk Score to Predict Early Major Bleeding in Acute Pulmonary Embolism

2021

Background Improved prediction of the risk of early major bleeding in pulmonary embolism (PE) is needed to optimize acute management. Research Question Does a simple scoring system predict early major bleeding in acute PE patients, identifying patients with either high or low probability of early major bleeding? Study Design and Methods From a multicenter prospective registry including 2,754 patients, we performed post hoc multivariable logistic regression analysis to build a risk score to predict early (up to hospital discharge) major bleeding events. We validated the endpoint model internally, using bootstrapping in the derivation dataset by sampling with replacement for 500 iterations. P…

Pulmonary and Respiratory Medicinemedicine.medical_specialtyFramingham Risk ScoreAnemiabusiness.industryBleedCritical Care and Intensive Care Medicinemedicine.diseaseLogistic regressionPulmonary embolismBrier scoreInternal medicinemedicineDerivationCardiology and Cardiovascular MedicinebusinessMajor bleedingChest
researchProduct

Survival and quality of life after early discharge in low-risk pulmonary embolism.

2020

IntroductionEarly discharge of patients with acute low-risk pulmonary embolism requires validation by prospective trials with clinical and quality-of-life outcomes.MethodsThe multinational Home Treatment of Patients with Low-Risk Pulmonary Embolism with the Oral Factor Xa Inhibitor Rivaroxaban (HoT-PE) single-arm management trial investigated early discharge followed by ambulatory treatment with rivaroxaban. The study was stopped for efficacy after the positive results of the predefined interim analysis at 50% of the planned population. The present analysis includes the entire trial population (576 patients). In addition to 3-month recurrence (primary outcome) and 1-year overall mortality, …

Pulmonary and Respiratory Medicinemedicine.medical_specialtyPopulationPatient subgroups030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineQuality of lifeInternal medicineSurveys and QuestionnairesMedicineHumansProspective StudieseducationEarly dischargeAgededucation.field_of_studyRivaroxabanbusiness.industrymedicine.diseaseInterim analysisPatient Discharge3. Good healthPulmonary embolism030228 respiratory systemAmbulatoryQuality of LifeFemalebusinessPulmonary Embolismmedicine.drugThe European respiratory journal
researchProduct

Pathophysiology of Impaired Right and Left Ventricular Function in Chronic Embolic Pulmonary Hypertension

2000

Study objectives: This study sought to evaluatethe pathophysiology of left and right heart failure in patients withchronic thromboembolic pulmonary hypertension (CTEPH) who werehospitalized to undergo pulmonary thromboendarterectomy (PTE). Design: Thirty-nine patients (16 women and 23 men;mean ± SD age, 55 ± 12 years) with severe CTEPH were examinedbefore and 13 ± 8 days after PTE by way of transthoracicechocardiography and right heart catheterization. Measurements and results: Examination resultsconfirmed in all cases that before surgery the right ventricles wereenlarged and systolic function was impaired. Moderate to severetricuspid valve regurgitation was observed. Left ventriculareccent…

Pulmonary and Respiratory Medicinemedicine.medical_specialtyPulmonary thromboendarterectomybusiness.industrymedicine.medical_treatmentDiastoleCritical Care and Intensive Care Medicinemedicine.diseasePulmonary hypertensionPulmonary embolismHeart failureInternal medicinemedicineVentricular pressureCardiologySystoleCardiology and Cardiovascular MedicinePulmonary wedge pressurebusinessChest
researchProduct

Long-term results after thromboendarterectomy for chronic pulmonary embolism1

1999

Objective: In patients with chronic thromboembolic pulmonary hypertension, pulmonary vascular resistance (PVR) can be reduced by pulmonary thromboendarterectomy (PTE). In this study, long-term symptomatic and hemodynamic effects were investigated. Methods: Twenty-two patients (12 female, 10 male, mean age 40 years, preoperative NYHA functional class II/III/IV: n = 1/12/9) were re-evaluated 48‐72 months (mean 60 months) after surgery. In addition to clinical assessment, radiologic, hemodynamic and echocardiographic investigations were performed. Results: All patients reported a marked improvement of their clinical condition. At follow-up, 11 patients were identified as NYHA class I, 10 as NY…

Pulmonary and Respiratory Medicinemedicine.medical_specialtyPulmonary thromboendarterectomybusiness.industrymedicine.medical_treatmentGeneral Medicinemedicine.diseasePreoperative careOxygen tensionPulmonary embolismSurgerymedicine.anatomical_structureBlood pressureInternal medicinemedicine.arteryPulmonary arterymedicineVascular resistanceCardiologySurgeryCardiology and Cardiovascular MedicinebusinessEndarterectomyEuropean Journal of Cardio-Thoracic Surgery
researchProduct

Impact of cancer on the effectiveness of cardiac Troponin I to predict right ventricular dysfunction in acute pulmonary embolism

2015

Background Deep vein thrombosis (DVT) and pulmonary embolism (PE) are connected with a poor outcome in cancer patients. We aimed to investigate the impact of cancer on the effectiveness of cardiac Troponin I (cTnI) to predict right ventricular dysfunction (RVD) in acute PE. Methods We retrospectively analyzed the data of 182 patients with confirmed PE. PE patients were subdivided into two groups: (i) with concomitant active cancer disease or history of cancer, and (ii) without known cancer. Receiver operating characteristic (ROC) curves with area under the curve (AUC) was calculated for cTnI predicting RVD and related cut-off levels for both groups. Results Thirty-seven PE patients (20.3%) …

Pulmonary and Respiratory Medicinemedicine.medical_specialtyReceiver operating characteristicbusiness.industryDeep veinArea under the curveCancerGeneral Medicinemedicine.diseaseThrombosisSurgeryPulmonary embolismmedicine.anatomical_structureOncologyConcomitantInternal medicineTroponin Icardiovascular systemmedicineCardiologybusinessThoracic Cancer
researchProduct

Comment évaluer le pronostic d’une embolie pulmonaire ?

2021

Pulmonary and Respiratory Medicinemedicine.medical_specialtyText miningbusiness.industryMEDLINEMedicinebusinessmedicine.diseaseIntensive care medicinePulmonary embolismRevue des Maladies Respiratoires
researchProduct

Systemic Thrombolytic Therapy for Acute Pulmonary Embolism: Who Is a Candidate?

2017

Pulmonary embolism (PE) is a major cause of both acute and long-term morbidity for a large number of patients worldwide, and massive PE is frequently fatal. Right ventricular (RV) dysfunction is a key determinant of prognosis in the acute phase of PE. Patients with clinically overt RV failure, that is, with cardiogenic shock or persistent hypotension at presentation (acute high-risk PE), are clearly in need of immediate reperfusion treatment with systemic thrombolysis or, alternatively, surgical or catheter-directed techniques. On the other hand, within the large group of patients presenting without hemodynamic instability, the bleeding risk of full-dose intravenous thrombolytic treatment h…

Pulmonary and Respiratory Medicinemedicine.medical_specialtyVentricular Dysfunction Rightmedicine.medical_treatmentHemodynamicsSalvage therapy030204 cardiovascular system & hematologyCritical Care and Intensive Care Medicine03 medical and health sciences0302 clinical medicineFibrinolytic AgentsInternal medicineFibrinolysismedicineHumansThrombolytic TherapyDecompensation030212 general & internal medicineWatchful WaitingIntensive care medicineSalvage Therapybusiness.industryCardiogenic shockAnticoagulantsThrombolysisPrognosismedicine.diseasePulmonary embolismAcute DiseaseCardiologyPulmonary EmbolismbusinessWatchful waitingSeminars in Respiratory and Critical Care Medicine
researchProduct

Inherited Thrombophilic Risk Factors and Venous Thromboembolism

2000

Study objectives To investigate whether the FIIA20210 mutation is associated with isolated pulmonaryembolism (PE). Design Case-control study. Setting Five thrombosis centers in southern Italy. Patients Six hundred forty-seven consecutive referredpatients with objectively documented venous thrombosis and 1,329control subjects. Measurements and results Medicalhistories were collected. The G-to-A transition at nucleotide 1691within the factor V gene (FV Leiden) and the G-to-A transition atnucleotide position 20210 within the prothrombin gene locus (FIIA20210), levels of anticoagulant factors, and levelsof antiphospholipid antibodies were determined by standard techniques.Patients with deep ven…

Pulmonary and Respiratory Medicinemedicine.medical_specialtybiologymedicine.drug_classbusiness.industryDeep veinAnticoagulantFactor VCritical Care and Intensive Care Medicinemedicine.diseaseGastroenterologyThrombosisSurgeryPulmonary embolismVenous thrombosismedicine.anatomical_structureInternal medicinemedicineFactor V Leidenbiology.proteinRisk factorCardiology and Cardiovascular MedicinebusinessChest
researchProduct

Management of acute pulmonary embolism: towards a (truly) global reach

2021

The study by Z. Zhai and colleagues provides an overview of the developments observed as risk-adapted management strategies for acute pulmonary embolism have been progressively introduced and optimised in the Chinese healthcare systemhttps://bit.ly/3swGht2

Pulmonary and Respiratory Medicinemedicine.medical_specialtybusiness.industry10031 Clinic for AngiologyMEDLINE610 Medicine & healthmedicine.diseasePulmonary embolism2740 Pulmonary and Respiratory MedicineHealth careAcute DiseaseMedicineHumansbusinessIntensive care medicinePulmonary Embolism
researchProduct